Quantcast
 
New book by Larry Connors Click here Improve your trading - See how


 

Zacks Analyst Blog Highlights: American Medical Systems Holdings, Inc., Wilmington Trust Corp., Silicon Lab, Inc., NII Holdings, Inc. and Shaw Communications Inc.

Mon. August 18, 2008; Posted: 06:00 AM
Stocks RSS
CHICAGO, Aug 18, 2008 (BUSINESS WIRE) -- WL | Quote | Chart | News | PowerRating -- Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: American Medical Systems Holdings, Inc. (Nasdaq: AMMD), Wilmington Trust Corp. (NYSE: WL), Silicon Lab, Inc. (Nasdaq: SLAB), NII Holdings, Inc. (Nasdaq: NIHD) and Shaw Communications Inc. (NYSE: SRJ).

Get the most recent insight from Zacks Equity Research with the free Profit from the Pros newsletter: http://at.zacks.com/?id=4579

Here are highlights from Friday's Analyst Blog:

American Medical Fairly Valued

American Medical Systems Holdings, Inc. (Nasdaq: AMMD | Quote | Chart | News | PowerRating) reported second-quarter revenue at the top of its prior guidance. EPS met the top range of guidance when excluding the royalty payment and normalizing for changes in interest expense. After adjusting for these factors, EPS still exceeded the analyst consensus.

Strong performance is attributed to solid expense management as a result of the numerous cost saving initiatives, legacy Men's health products. Laser Therapy continues to be weak, declining 11 percent in the quarter. Women's health continues to underperform expectations although incontinence revenues were strong with MiniArc driving growth.

Wilmington Trust Under Pressure

Wilmington Trust Corporation's (NYSE: WL | Quote | Chart | News | PowerRating) 2Q08 operating earnings of $0.47 per diluted share were two pennies short of consensus.

WL currently trades at 11.1 times the consensus forward estimate (versus 13.6 times at the time of our last full report), at 5% discount to the peer group median (versus at par at that time). On a price-to-book basis, the shares trade at 29% premium to the peer median, versus a 47% premium earlier. Relative pricing continues to look attractive on a P/E-to-growth (PEG) basis (using the consensus forward estimate and the consensus long-term growth rate).

Silicon Lab Rev Outlook Murky

Silicon Lab, Inc. (Nasdaq: SLAB | Quote | Chart | News | PowerRating) sold its Aero and power amplifier business to NXP for $285 million and therefore no longer competes in the ultra competitive wireless space. This has pushed gross margins in to the low 60% range.

Forward guidance calls for a 6-10% sequential revenue increase. A number of new products have the potential to grow at 30-50%. Consequently, we are maintaining the current Hold rating on SLAB shares.

NII Latin Growth Warrants Caution

NII Holdings, Inc. (Nasdaq: NIHD), formerly known as Nextel International, is licensed to provide wireless services in Mexico, Brazil, Argentina and Peru.

The company reported stronger than expected results in the recent quarter which were highlighted by improvement in profitability driven by robust subscriber growth. NIHD announced intentions of higher capital spending in 2008 to expand the geographic coverage of its iDEN network. Overall demand for wireless services in Latin America remains strong and key growth markets, including Brazil and Mexico, offer financial growth opportunities.

Shaw Comm Markets Maturing

We assumed coverage of Shaw Communications (NYSE: SJR) in February 2007. We think SJR can grow EPS at a CAGR of at least 15%-17% over the next five years, driven by the acquisition of cable systems, the rollout of digital telephony and the country's fastest Internet service, coupled with continuing share buybacks.

Moreover, continued share buybacks, funded by free cash flow and coupled with the increased dividend, will boost total shareholder return. However, a mature market for high-speed Internet service and the uncertainty surrounding the sustainability of the positive trends in the Star Choice business, contribute to a high risk/reward ratio in the stock at its current high valuation multiples.

Want more from Zacks Equity Research? Subscribe to the free Profit from the Pros newsletter: http://at.zacks.com/?id=2649.

About Zacks Equity Research

Zacks Equity Research provides the best of quantitative and qualitative analysis to help investors know what stocks to buy and which to sell for the long-term.

Continuous coverage is provided for a universe of 1,150 publicly traded stocks. Our analysts are organized by industry which gives them keen insights to developments that affect company profits and stock performance. Recommendations and target prices are six-month time horizons.

Zacks "Profit from the Pros" e-mail newsletter provides highlights of the latest analysis from Zacks Equity Research. Subscribe to this free newsletter today: http://at.zacks.com/?id=2677

About Zacks

Zacks.com is a property of Zacks Investment Research, Inc., which was formed in 1978 by Leonard Zacks. As a PhD in mathematics Len knew he could find patterns in stock market data that would lead to superior investment results. Amongst his many accomplishments was the formation of his proprietary stock picking system; the Zacks Rank, which continues to outperform the market by nearly a 3 to 1 margin. The best way to unlock the profitable stock recommendations and market insights of Zacks Investment Research is through our free daily email newsletter; Profit from the Pros. In short, it's your steady flow of Profitable ideas GUARANTEED to be worth your time! Register for your free subscription to Profit from the Pros at http://at.zacks.com/?id=4580.

Visit http://www.zacks.com/performance for information about the performance numbers displayed in this press release.

Disclaimer: Past performance does not guarantee future results. Investors should always research companies and securities before making any investments. Nothing herein should be construed as an offer or solicitation to buy or sell any security.

SOURCE: Zacks.com

Zacks.com Mark Vickery Web Content Editor 312-265-9380 Visit: www.zacks.com

For full details on American Medical Systems (AMMD) click here. American Medical Systems (AMMD) has Short Term PowerRatings of 7. Details on American Medical Systems (AMMD) Short Term PowerRatings is available at This Link.

    


More News:   Market Updates | Stock Alerts | All Trading News | Stock Index

Email
Print
Archives
Feedback
Email Article Link
Close X
Recipients email address
Your name
Your email
Add a note (optional)




Stocks RSS





Related News [AMMD]
PREMIER SPONSORED LINKS
TRADE CENTER
 
The TradingMarkets Directory
RELATED SITES
Nothing but forex
Please call 1-213-955-5858 ext. 1

About TradingMarkets | Contact | Advertise | Careers | Link to Us | Site Map | Help | Terms & Conditions | Privacy Policy | Return Policy | Testimonials | Feedback

Disclaimer:

The Connors Group, Inc. ("Company") is not an investment advisory service, nor a registered investment advisor or broker-dealer and does not purport to tell or suggest which securities or currencies customers should buy or sell for themselves. The analysts and employees or affiliates of Company may hold positions in the stocks, currencies or industries discussed here. You understand and acknowledge that there is a very high degree of risk involved in trading securities and/or currencies. The Company, the authors, the publisher, and all affiliates of Company assume no responsibility or liability for your trading and investment results. Factual statements on the Company's website, or in its publications, are made as of the date stated and are subject to change without notice.

It should not be assumed that the methods, techniques, or indicators presented in these products will be profitable or that they will not result in losses. Past results of any individual trader or trading system published by Company are not indicative of future returns by that trader or system, and are not indicative of future returns which be realized by you. In addition, the indicators, strategies, columns, articles and all other features of Company's products (collectively, the "Information") are provided for informational and educational purposes only and should not be construed as investment advice. Examples presented on Company's website are for educational purposes only. Such set-ups are not solicitations of any order to buy or sell. Accordingly, you should not rely solely on the Information in making any investment. Rather, you should use the Information only as a starting point for doing additional independent research in order to allow you to form your own opinion regarding investments. You should always check with your licensed financial advisor and tax advisor to determine the suitability of any investment.

HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN INHERENT LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING AND MAY NOT BE IMPACTED BY BROKERAGE AND OTHER SLIPPAGE FEES. ALSO, SINCE THE TRADES HAVE NOT ACTUALLY BEEN EXECUTED, THE RESULTS MAY HAVE UNDER- OR OVER-COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFITS OR LOSSES SIMILAR TO THOSE SHOWN.

The Connors Group, Inc.
15260 Ventura Blvd., Ste. 2200
Sherman Oaks, CA 91403

© Copyright 2009 The Connors Group, Inc.


All analyst commentary provided on TradingMarkets.com is provided for educational purposes only. The analysts and employees or affiliates of TradingMarkets.com may hold positions in the stocks or industries discussed here. This information is NOT a recommendation or solicitation to buy or sell any securities. Your use of this and all information contained on TradingMarkets.com is governed by the Terms and Conditions of Use. Please click the link to view those terms. Follow this link to read our Editorial Policy.

© 2009 The Connors Group, Inc.